• Quaternization Enables Lung-Targeted mRNA Delivery via Nanoa

  2026-06-04

  The referenced study demonstrates that quaternization of lipid-like nanoassemblies reverses organ selectivity of mRNA delivery from the spleen to the lung following systemic administration. This finding offers a streamlined strategy for lung-targeted mRNA therapeutics, potentially broadening applications in pulmonary gene therapy.

• Inducing Lhx1-Expressing Spermatogonia-like Cells from Mouse

  2026-06-04

  This study presents an optimized chemical protocol enabling the in vitro differentiation of mouse embryonic stem cells into spermatogonia-like cells with enhanced expression of the key stem cell marker Lhx1. The approach advances germline modeling and offers a foundation for dissecting the epigenetic regulation of male germ cell development.

• USP42 Drives Breast Cancer by Blocking JNK/p38 Apoptosis Pat

  2026-06-03

  This study uncovers how the deubiquitinating enzyme USP42 promotes breast cancer progression by suppressing apoptosis through inhibition of the JNK and p38 MAPK signaling pathways. These mechanistic insights highlight USP42 as a promising molecular target for breast cancer therapy and provide a foundation for future translational research.

• THBS1 Identified as Prognostic Biomarker in Laryngeal Cancer

  2026-06-03

  A recent integrative analysis pinpointed THBS1 as a key prognostic biomarker and potential therapeutic target in laryngeal cancer. By combining bioinformatics and experimental validation, the study links THBS1 to immune suppression and altered lipid metabolism, providing actionable insights for future biomarker-driven therapies.

• Caspase-3 and ERO1α Drive Mitochondrial ROS in Trichothecene

  2026-06-02

  This study reveals a mechanism by which trichothecene mycotoxins induce liver damage: caspase-3-mediated cleavage of NDUFS1 and ER-localized ERO1α together amplify mitochondrial and ER oxidative stress. These findings clarify the molecular interplay underlying mycotoxin-driven ROS accumulation and highlight actionable targets for mitigating hepatotoxicity.

• Septin4 Enhances Cardiomyocyte Apoptosis by Promoting HIF-1α

  2026-06-02

  This study uncovers the role of Septin4 in aggravating hypoxia-induced apoptosis of cardiomyocytes by facilitating VHL-mediated degradation of HIF-1α. The findings highlight a novel regulatory axis relevant to myocardial hypoxia injury, offering mechanistic insight for future interventions.

• gamma-Glu-Cys: Optimizing Peptide Synthesis & Glutathione Re

  2026-06-01

  gamma-Glu-Cys (γ-Glu-Cys) from APExBIO is pivotal for next-gen glutathione metabolism research and kokumi peptide engineering, offering unmatched workflow flexibility and reproducibility. Discover advanced experimental approaches, troubleshooting strategies, and new findings that directly inform your protocols.

• Nintedanib (BIBF 1120): Applied Workflows for Cancer & Fibro

  2026-06-01

  Nintedanib (BIBF 1120) is transforming antiangiogenic and antifibrotic research by targeting VEGFR, PDGFR, and FGFR signaling with nanomolar potency. Explore optimized protocols, advanced use-cases, and troubleshooting strategies that empower scientists to harness its full translational potential.

• Photothermal Therapy and CD47 Blockade Synergy in OSCC

  2026-05-31

  This study reveals that combining photothermal therapy (PTT) with CD47 blockade significantly enhances macrophage-mediated tumor clearance in oral squamous cell carcinoma (OSCC). By inducing calreticulin exposure and remodeling the tumor extracellular matrix, the combined approach overcomes key barriers in the tumor microenvironment, offering new mechanistic insights for immunotherapy optimization.

• PF-562271 HCl: Optimizing FAK/Pyk2 Inhibition in Cancer Rese

  2026-05-30

  PF-562271 HCl stands out as a precise, reversible FAK/Pyk2 inhibitor, enabling targeted dissection of focal adhesion kinase signaling in tumor biology. This guide details stepwise experimental workflows, advanced applications, and troubleshooting strategies, anchored in recent mechanistic insights and benchmarked against emerging immunomodulatory research.

• (-)-JQ1: Precision Inactive Control for BET Inhibition Studi

  2026-05-29

  (-)-JQ1 sets the benchmark for specificity in epigenetics and cancer biology research as the rigorously validated JQ1 stereoisomer. This guide explores actionable workflows, troubleshooting strategies, and comparative insights that harness (-)-JQ1 to maximize experimental clarity in BET bromodomain studies.

• Geneticin, G-418 Sulfate (A2513): Precision Selection & Anti

  2026-05-29

  This article delineates key laboratory challenges in genetic engineering and antiviral research, demonstrating how Geneticin, G-418 Sulfate (SKU A2513) delivers reproducible results and workflow reliability. Evidence-backed scenarios address protocol optimization, data interpretation, and vendor selection, positioning this compound as an essential tool for rigorous cell-based assays.

• Cyanine 5-dCTP: Redefining Enzymatic DNA Fluorescent Labelin

  2026-05-28

  Explore how Cyanine 5-dCTP enables precise, high-yield fluorescent DNA labeling for next-generation enzymatic synthesis and molecular assays. This article reveals new insights into DNA framework innovations and practical protocol design.

• SGI-1027 and Everolimus Induce Synergistic Cell Death in RCC

  2026-05-28

  This study reveals that SGI-1027, a DNA methyltransferase inhibitor, triggers methuosis and potentiates everolimus-induced cytotoxicity in renal cancer by promoting lysosomal membrane permeability and activating apoptosis and pyroptosis. The findings highlight a novel combinatorial strategy to overcome resistance in advanced renal cell carcinoma.

• Periodontopathogen Proteases Generate Angiotensin (1-7) from

  2026-05-27

  This study uncovers a novel mechanism by which Porphyromonas gingivalis and Tannerella forsythia, key periodontopathogens, degrade angiotensin I to produce Angiotensin (1-7) via unique surface proteases. The findings highlight a direct microbial modulation of the renin–angiotensin system, reshaping our understanding of oral-systemic disease links and the local anti-inflammatory landscape.

552 records 16/37 page Previous Next First page 上5页 1617181920 下5页 Last page